Selecta Biosciences, Inc. (SELB) Q3 2020 Earnings Call Transcript ... Good morning and welcome to the Selecta Biosciences Third quarter 2020 ... for poster presentation at San Antonio Breast Cancer Virtual Symposium taking ...
News
- Selecta Biosciences, Inc. (SELB) Q3 2020 Earnings Call Transcript
- Next week the Talent Land Latin America will be held
... DEFI, medicine and biotechnology, musical innovation, technologies of the future, e-sports, tools for innovation and adaptation to business change.
- COVID-19 vaccine clinical trials recruiting volunteers in Houston, other Texas cities
... in our accelerated timeline,” he said, noting the Biomedical Advanced Research and Development Authority employed robust evaluation standards ...
- Initial public offerings scheduled to debut next week
Proposed Nasdaq symbol INAB. Business: Phase 1 oncology biotech developing allogeneic gamma-delta T cell therapies. Most Popular. Nevada is ...
- GlycoMimetics: 3Q Earnings Snapshot
The biotechnology company posted revenue of $1 million in the period. The company's shares closed at $3.05. A year ago, they were trading at $5.84.